Clinical Trials Browser

Phase 3 × Interventional × Ototoxicity × Clear all

NCT00652132 2018-05-29

SIOPEL6

Phase 3 Completed

116 enrolled 1 FDA

Gastrointestinal

Ototoxicity, Liver Neoplasms, Hepatoblastoma

NCT01216800 2010-10-07

Intensity-Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Decreasing Hearing Loss in Patients Who Have Undergone Surgery for Parotid Tumors

Phase 3 Unknown

Ototoxicity, Head and Neck Neoplasms, Radiation Injuries, Salivary Gland Neoplasms